VCYT
VERACYTE, INC.NasdaqResearch view
Healthcare · Services-Medical Laboratories · Mid-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$3.2B
Enterprise Value$2.8B
Income$66.4M
Sales$517.1M
Book/sh$16.29
Cash/sh$4.53
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio7.81
Current Ratio8.15
Debt/Eq—
EPS (ttm)$0.82
EPS this Y164.5%
EPS past 3/5Y—
Sales past 3/5Y20.4%
EPS Y/Y TTM164.5%
Sales Y/Y TTM16.0%
Shs Outstand80.39M
ROA4.7%
ROE5.1%
ROIC5.9%
Gross Margin70.1%
Oper. Margin11.2%
Profit Margin12.8%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$219.5M
2021
$296.5M
2022
$361.1M
2023
$445.8M
2024
$517.1M
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $219.5M | $296.5M | $361.1M | $445.8M | $517.1M |
| Gross Profit | — | $175.7M | $229.7M | $298.1M | $362.5M |
| Operating Income | $-81.9M | $-41.1M | $-85.8M | $16.1M | $57.8M |
| Net Income | $-75.6M | $-36.6M | $-74.4M | $24.1M | $66.4M |
| Diluted EPS | $-1.11 | $-0.51 | $-1.02 | $0.31 | $0.82 |
| Operating Cash Flow | $-31.6M | $7.5M | $44.2M | $75.1M | $136.3M |
| Free Cash Flow | $-37.0M | $-1.0M | $34.3M | $63.8M | $126.6M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $9.7M against $136.3M operating cash
COMMUNITY · $VCYT0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Services-Medical Laboratories
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.